Matteo Stravalaci

2.8k total citations
38 papers, 1.8k citations indexed

About

Matteo Stravalaci is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Matteo Stravalaci has authored 38 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Physiology and 12 papers in Immunology. Recurrent topics in Matteo Stravalaci's work include Alzheimer's disease research and treatments (12 papers), Prion Diseases and Protein Misfolding (7 papers) and Biomarkers in Disease Mechanisms (6 papers). Matteo Stravalaci is often cited by papers focused on Alzheimer's disease research and treatments (12 papers), Prion Diseases and Protein Misfolding (7 papers) and Biomarkers in Disease Mechanisms (6 papers). Matteo Stravalaci collaborates with scholars based in Italy, United Kingdom and United States. Matteo Stravalaci's co-authors include Marco Gobbi, Mario Salmona, Marten Beeg, Emiliano Biasini, Antonio Bastone, Laura Colombo, Tiziana Borsello, Alessandra Sclip, Claudia Balducci and Gianluigi Forloni and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Matteo Stravalaci

38 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matteo Stravalaci Italy 22 973 766 455 359 165 38 1.8k
Masanori Honsho Japan 29 3.1k 3.2× 835 1.1× 289 0.6× 222 0.6× 194 1.2× 55 3.8k
Robyn A. Sharples Australia 19 1.9k 1.9× 683 0.9× 164 0.4× 188 0.5× 129 0.8× 24 2.6k
Daniela Sarnataro Italy 27 1.5k 1.5× 415 0.5× 125 0.3× 247 0.7× 158 1.0× 56 2.2k
Angela Cattaneo Italy 24 1.1k 1.1× 272 0.4× 359 0.8× 131 0.4× 168 1.0× 45 2.1k
Simona Paladino Italy 34 1.9k 2.0× 532 0.7× 176 0.4× 185 0.5× 157 1.0× 80 2.9k
Jordan B. Fishman United States 20 816 0.8× 294 0.4× 195 0.4× 132 0.4× 253 1.5× 57 1.6k
Benjamin M. Petre United States 13 1.4k 1.5× 1.3k 1.8× 233 0.5× 209 0.6× 346 2.1× 32 3.4k
Deborah A. Fraser United States 19 778 0.8× 322 0.4× 1.2k 2.6× 503 1.4× 114 0.7× 31 2.7k
Rebecca M. Nisbet Australia 19 948 1.0× 738 1.0× 75 0.2× 357 1.0× 289 1.8× 37 2.0k
Valeria Manganelli Italy 27 1.3k 1.4× 277 0.4× 239 0.5× 115 0.3× 147 0.9× 77 2.1k

Countries citing papers authored by Matteo Stravalaci

Since Specialization
Citations

This map shows the geographic impact of Matteo Stravalaci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Stravalaci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Stravalaci more than expected).

Fields of papers citing papers by Matteo Stravalaci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matteo Stravalaci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Stravalaci. The network helps show where Matteo Stravalaci may publish in the future.

Co-authorship network of co-authors of Matteo Stravalaci

This figure shows the co-authorship network connecting the top 25 collaborators of Matteo Stravalaci. A scholar is included among the top collaborators of Matteo Stravalaci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matteo Stravalaci. Matteo Stravalaci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raimondi, Raffaele, et al.. (2022). Where Are We with RPE Replacement Therapy? A Translational Review from the Ophthalmologist Perspective. International Journal of Molecular Sciences. 23(2). 682–682. 12 indexed citations
2.
Piovani, Daniele, Sarah N. Mapelli, Roberto Leone, et al.. (2022). A cytokine/PTX3 prognostic index as a predictor of mortality in sepsis. Frontiers in Immunology. 13. 979232–979232. 16 indexed citations
3.
Stravalaci, Matteo, Mariantonia Ferrara, Varun Pathak, et al.. (2022). The Long Pentraxin PTX3 as a New Biomarker and Pharmacological Target in Age-Related Macular Degeneration and Diabetic Retinopathy. Frontiers in Pharmacology. 12. 811344–811344. 16 indexed citations
4.
Bally, Isabelle, Antonio Inforzato, Fabien Dalonneau, et al.. (2019). Interaction of C1q With Pentraxin 3 and IgM Revisited: Mutational Studies With Recombinant C1q Variants. Frontiers in Immunology. 10. 461–461. 23 indexed citations
5.
Stincardini, Claudia, Tania Massignan, Saioa R. Elezgarai, et al.. (2017). An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein. PLoS ONE. 12(8). e0182589–e0182589. 12 indexed citations
6.
Joshi, Pooja, Martina Gabrielli, Luisa Ponzoni, et al.. (2017). Fingolimod Limits Acute Aβ Neurotoxicity and Promotes Synaptic Versus Extrasynaptic NMDA Receptor Functionality in Hippocampal Neurons. Scientific Reports. 7(1). 41734–41734. 27 indexed citations
7.
Stravalaci, Matteo, Laura Tapella, Marten Beeg, et al.. (2016). The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers. Journal of Alzheimer s Disease. 53(4). 1485–1497. 10 indexed citations
8.
Diomede, Luisa, Margherita Romeo, Alfredo Cagnotto, et al.. (2016). The new β amyloid-derived peptide Aβ1–6A2V-TAT(D) prevents Aβ oligomer formation and protects transgenic C. elegans from Aβ toxicity. Neurobiology of Disease. 88. 75–84. 19 indexed citations
9.
Stravalaci, Matteo, Daiana De Blasio, Franca Orsini, et al.. (2016). A New Surface Plasmon Resonance Assay for In Vitro Screening of Mannose-Binding Lectin Inhibitors. SLAS DISCOVERY. 21(7). 749–757. 9 indexed citations
10.
Massignan, Tania, Claudia Stincardini, Milica Cerovic, et al.. (2016). A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein. Scientific Reports. 6(1). 23180–23180. 25 indexed citations
11.
Beeg, Marten, Matteo Stravalaci, Margherita Romeo, et al.. (2016). Clusterin Binds to Aβ1–42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation. Journal of Biological Chemistry. 291(13). 6958–6966. 95 indexed citations
12.
Biasini, Emiliano, Matteo Stravalaci, Alessandra Sclip, et al.. (2013). An N-terminal Fragment of the Prion Protein Binds to Amyloid-β Oligomers and Inhibits Their Neurotoxicity in Vivo. Journal of Biological Chemistry. 288(11). 7857–7866. 156 indexed citations
13.
Beeg, Marten, Luisa Diomede, Matteo Stravalaci, Mario Salmona, & Marco Gobbi. (2013). Novel approaches for studying amyloidogenic peptides/proteins. Current Opinion in Pharmacology. 13(5). 797–801. 17 indexed citations
14.
Stravalaci, Matteo, Antonio Bastone, Marten Beeg, et al.. (2012). Specific Recognition of Biologically Active Amyloid-β Oligomers by a New Surface Plasmon Resonance-based Immunoassay and an in Vivo Assay in Caenorhabditis elegans. Journal of Biological Chemistry. 287(33). 27796–27805. 51 indexed citations
15.
16.
Stravalaci, Matteo, Marten Beeg, Mario Salmona, & Marco Gobbi. (2010). Use of surface plasmon resonance to study the elongation kinetics and the binding properties of the highly amyloidogenic Aβ1–42 peptide, synthesized by depsi-peptide technique. Biosensors and Bioelectronics. 26(5). 2772–2775. 34 indexed citations
17.
Colombo, Giorgio, Laura Ragona, Marco A. C. Neves, et al.. (2010). Non-peptidic Thrombospondin-1 Mimics as Fibroblast Growth Factor-2 Inhibitors. Journal of Biological Chemistry. 285(12). 8733–8742. 63 indexed citations
18.
19.
Gesuete, Raffaella, Claudio Storini, Alessandro Fantin, et al.. (2009). Recombinant C1 inhibitor in brain ischemic injury. Annals of Neurology. 66(3). 332–342. 103 indexed citations
20.
Biasini, Emiliano, Laura Tapella, Susanna Mantovani, et al.. (2009). Immunopurification of Pathological Prion Protein Aggregates. PLoS ONE. 4(11). e7816–e7816. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masanori Honsho Breakdown of academic impact, for papers by Robyn A. Sharples Breakdown of academic impact, for papers by Daniela Sarnataro Breakdown of academic impact, for papers by Angela Cattaneo Breakdown of academic impact, for papers by Simona Paladino Breakdown of academic impact, for papers by Jordan B. Fishman Breakdown of academic impact, for papers by Benjamin M. Petre Breakdown of academic impact, for papers by Deborah A. Fraser Breakdown of academic impact, for papers by Rebecca M. Nisbet Breakdown of academic impact, for papers by Valeria Manganelli
Rankless by CCL
2026